Naringenin accords hepatoprotection from streptozotocin induced diabetes in vivo by modulating mitochondrial dysfunction and apoptotic signaling cascade  by Kapoor, Radhika & Kakkar, Poonam
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Diabetic  complications  cause  noticeable  liver  damage,  which  ﬁnally  progresses  to diabetic
hepatopathy.  Nutritive  antioxidants  not  only  reduce  the  liver  damage,  but  also  prevent
it by  modulating  the  release  of various  proteins  involved  in  apoptotic  signaling  cascades.
This  study  explores  the  molecular  mechanisms  underlying  diabetes-induced  liver  damage
and its modulation  by  naringenin.  Antioxidant  status,  liver  & kidney  biomarker  enzymes,
reactive  oxygen  species  (ROS)  generation,  mitochondrial  membrane  potential,  expression
of apoptotic  proteins  like  Bax (bcl-2  associated  X),  Bcl-2  (b-cell  Lymhoma-2),  Caspase-3,
Caspase-9,  AIF  (Apoptosis  inducing  factor)  and Endo-G  (Endonuclease-G)  were  studied  in
streptozotocin  induced  diabetic  rats.  Signiﬁcant  hyperglycemia,  disturbed  antioxidant  sta-
tus, altered  carbohydrate  metabolizing  enzymes,  increased  ROS  and  lipid  peroxidation;
decreased  mitochondrial  membrane  potential  and  enhanced  release  of  AIF  and  Endo-G
were observed.  Hyperglycemia  also affected  apoptosis  and  its related  genes  at both  trans-
criptional  and  translational  level  (Caspase-3  & 9, Bax and  Bcl-2)  in the  liver  of  diabetic  rats.
Naringenin,  a ﬂavonone,  exerted  anti-hyperglycemic  effect  and  was  able  to prevent oxida-
tive stress  and resultant  apoptotic  events  caused  due  to diabetes-induced  hepatotoxicity.
Thus,  our  study  shows,  a protective  effect  of naringenin  against  diabetes  induced  liver dam-
age and  redox  imbalance,  which  could  further  be  exploited  for the  management  of diabetic
hepatopathy.poptosis
treptozotocin induced diabetes
itochondrial dysfunction
xidative  stress
aringenin
iver  damage
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
the CC  BY  license  (http://creativecommons.org/licenses/by/3.0/).
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1. Introduction
Diabetes mellitus, characterized by high blood sugar, is
a  disorder related to deﬁciency of insulin secretion/action
or both. The prevalence and mortality due to this chronic
metabolic disease have been reported in both developed
and developing countries. Though the leading mechanism
of  diabetic complications remains unclear, oxidative dam-
age  is considered as one of the major causative factors
[12,32,33]. Scientiﬁc reports show enhanced generation of
reactive  oxygen species (ROS) in both types of diabetes
(Type-1 and Type-2), which relates oxidative stress to the
onset  of diabetes [10]. Four important metabolic pathways
namely PKC (Protein Kinase-C), hexosamine, advanced
glycation and polyol pathway induce overproduction of
reactive  oxygen species (ROS) in mitochondria during
hyperglycemia [6]. This excessive ROS generation, in turn,
induces  various metabolic dysfunctions and contributes to
progressive  development of micro-/macro vascular com-
plications and multi-organ damage.
Liver is the main organ of glucose homeostasis, oxida-
tive  processes and detoxiﬁcation site for major metabolites
produced as a repercussion of excessive ROS and holds
importance during the progression of diabetes. Hence, the
inhibition  of ROS generation can be an important strategy
to  restore normal functioning of the liver and control the
progression of diabetes-induced liver damage. Apoptosis
is  a common form of cell death morphologically character-
ized by cellular shrinkage, chromatin condensation, DNA
fragmentation and cell disruption into apoptotic bodies.
Generation of excessive free radicals due to hyperglycemia
and onset of apoptosis has been reported in scientiﬁc
literature [35,42]. Release of apoptotic proteins like AIF
(Apoptosis Inducing factor), Endo-G (Endo nuclease-G),
Bax (bcl-2 associated X), Bcl-2 (b-cell Lymhoma-2) and
caspases has been well demonstrated by our group dur-
ing  drug induced hepatotoxicity and hyperglycemia under
in  vitro conditions [14,15,34].
Various  researchers suggest that phytochemical from
traditionally known medicinal plants have been exten-
sively used as an alternative medicine for the management
of diabetes. Literature suggests that ﬂavanones are poten-
tially  used as an anti-diabetic agent due to their chemical
structure [23]. Recent scientiﬁc reports show that narin-
genin  suppresses carbohydrate absorption in the intestine
and  thereby prevents the increased post-prandial glucose
in  diabetic patients [5]. A recent study showed naringenin
to  be better as compared to hesperedin and hesperitin (its
related  citrus ﬂavanones) as far as interaction with intra-
cellular enzymes, mitochondrial and cellular membrane is
concerned.  Moreover, the inhibition of the gluconeogenic
pathway by the citrus ﬂavanones like naringenin has been
found  similar to that of metformin in a recent report [5]. We
initially  studied the effect of several ﬂavanones against high
glucose  induced cell death in hepatocytes (data not shown)
out  of which naringenin was selected for the present study.
Flavonoids are widely recognized as capable of lowering
both ROS generation and high circulating blood glucose.
Naringenin, a ﬂavanone, is considered to have beneﬁcial
effects on human health. It is considered a good anti-
inﬂammatory agent, improves carbohydrate metabolismeports 1 (2014) 569–581
and  immune system. It is one of the major constituents of
grapefruit, Citrus paradisi, which is traditionally known to
have  medicinal importance. We  have previously reported
that  naringenin exerts its protective effect in high glucose
(40  mM)  stressed hepatocytes in vitro by inhibiting the
release  of apoptotic proteins and maintaining antioxidant
status of the cells [15]. Recent research reports suggest the
anti  hyperglycemic effect of naringenin [3,29], but to the
best  of our knowledge, mechanism involved in apoptosis
caused during diabetes induced liver damage and its ame-
lioration  by naringenin has not been reported.
In view of the above ﬁndings, the present study aims to
unveil  the anti hyperglycemic potential of naringenin by
exploring  its protective action against apoptosis in strepto-
zotocin  induced diabetic rats in vivo. The results obtained
from  the present study suggest that naringenin prevents
hyperglycemia-induced apoptotic cell death by modulat-
ing  ROS generation and mitochondria mediated apoptotic
cell  death. Besides acting as an antioxidant, naringenin has
an  important preventive role in hyperglycemia-induced
liver damage.
2.  Materials and methods
2.1.  Chemicals
All  chemicals used in the study were procured from
Sigma Chemicals Co. (St. Louis, MO,  USA). Chemicals used
from  other sources have been stated otherwise.
2.2. Animals
Male Wistar rats of 150–200 g from Indian Institute
of Toxicology Research (IITR) animal colony were used
in  the study. Rats were kept under standard condition of
25  ± 2 ◦C temperature, 60–70% humidity and a controlled
12 h light/dark cycle. Rats were given a standard pellet diet
(Ashirwad Pellet Diet, Mumbai, India) and water ad libi-
tum.  Animal handling in all experimental procedures was
approved  by the Institutional Animal Ethics Committee,
(ITRC/IAEC/22/2011). The animals were randomized into
control  and experimental groups and housed in different
cages.
2.3.  Induction and assessment of diabetes mellitus
In Wistar rats, diabetes was induced by single intraperi-
toneal injection of streptozotocin (65 mg/kg bwt) dissolved
in  normal saline. Prior to diabetes induction, rats were
treated with 110 mg/kg bwt. nicotinamide. Nicotinamide
is used prior to streptozotocin injection so that the beta-
cytotoxic effect of streptozotocin is partially protected.
Furthermore, when compared to available diabetic mod-
els,  the diabetic rat model developed with this protocol
is  found closer to non-insulin-dependent diabetes melli-
tus  with regard to insulin responsiveness to glucose and
sulfonylureas [27]. After four days of streptozotocin treat-
ment,  rats were fasted overnight and identiﬁed as diabetic
on  the basis of blood glucose levels (higher than 250 mg/dL)
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n tail blood using Glucometer (MediSense Optimum TM
ceed,  Abott Diabetes Care Inc. Almeda, USA).
.3.1. Oral glucose tolerance test
For oral glucose tolerance test (OGTT), ﬁve control rats
ere  grouped in one group while 25 diabetic rats were
urther divided into ﬁve groups (n = 5) from Group II to
roup  VI. After 18 h fasting, initial blood-glucose level
BGL) was estimated (0 min). Glucose solution (2 g/kg bwt)
as  administered by oral gavage from group I to group VI.
t  the same time, group III, IV and V received naringenin at
 dose of 25 mg/kg bwt, 50 mg/kg bwt  and 100 mg/kg bwt
rally,  respectively, while group VI received standard drug
lybenclamide (0.6 mg/kg bwt). Blood glucose was further
onitored at four more cardinal points at time intervals of
eadings  30, 60, 90, and 120 min  after glucose and test sam-
le  administration. Set of animals used in this experiment
s  different from that of used in the main study; the aim of
his  particular experiment was to ﬁnd out an effective dose
f  naringenin against hyperglycemia induced apoptosis in
iver  of rats. 100 mg/kg bwt dose of naringenin is refereed
s  the human relevant dose in the literature [39]. Study of
ifferent  doses of naringenin lower than 100 mg/kg bwt,
an  give insight into the possible human use of lower but,
ffective dose.
.3.2.  Treatment schedule
On  the basis of oral glucose tolerance test, effective
ose of naringenin (50 mg/kg bwt) was selected for further
xperiments. Diabetic rats and control rats were further
ivided into groups of six animals per group. Dose regimen
as  started from the next day after conﬁrmation of non-
nsulin-dependent diabetes mellitus and continued up to
0  days. Detail of experimental groups is as under:
Group 1 Control rats given normal saline; Ctrl
Group  2 Diabetic rats given normal saline; Diab
Group  3 50 mg/kg Naringenin given along with diabetes
induction;  Co-naringenin; CoN
Group  4 50 mg/kg Naringenin given to diabetic rats;
Post-naringenin; PoN
Group 5 Diabetic rats given Glibenclamide 0.6 mg/kg (positive
drug  control); Glib
Group 6 Diabetic rats given Silymarin 200 mg/kg; Sil (positive
phytochemical  control)
Group 7 Control rats given Naringenin 50 mg/kg; CtN
In one of the previous studies from our lab [37], sily-
arin administered to rats at 200 mg/kg bwt did not exhibit
ny  toxicity or signiﬁcant change in antioxidant enzymes,
ence, to save animals, group of control silymarin was not
ncluded  in the study.
.4. Measurement of general clinical parameters
.4.1. Measurement of body weight and fasting blood
lucoseThe body weight of all groups of animals was monitored
aily at a ﬁxed time. Fixed amount of rat food and ﬂuid was
iven  to each group and reﬁlled the next day. Fasting blood
lucose  was regularly monitored weekly.eports 1 (2014) 569–581 571
2.4.2. Liver function tests through biochemical
parameter analysis
Serum  was  separated from the blood. The activities
of glutamic oxaloacetic transaminase (GOT), Glutamic
Pyruvic Transaminase (GPT), ALP (alkaline phosphatase),
cholesterol, blood glucose, level of creatinine, albumin,
total bilirubin, blood urea nitrogen, and total protein were
measured using clinical autoanalyzer (Chemwell 2910,
USA).
2.4.3.  Tissue collection and preparation of homogenate
All animals were euthanized using chloroform and sac-
riﬁced.  Blood was  collected from the jugular vein of animals
in  EDTA coated vials. Tissue was collected in ice cold
phosphate buffer saline (PBS), weighed and homogenized.
Tissue homogenate (10% w/v) was made in 10 mM sodium
phosphate buffer using an electric motor with Teﬂon glass
and  pestle [20]. The entire procedure was  carried out under
cold  conditions.
2.5.  Protein estimation
Protein  estimation was  done by using standard protocol
of  [21]. Bovine serum albumin was used as standard and the
color  developed was read at 660 nm on Spectramax Plus
384  (Molecular Devices, USA).
2.6. Carbohydrate metabolizing enzyme assays
2.6.1. Glucokinase
For  Glucokinase activity (EC: 2.7.1.2), 100 l of 10%
tissue homogenate was added to the reaction mix-
ture containing 0.1 M Tris buffer (pH = 7.4), 0.2 mm
NADP+, 5 mM ATP, 5 mM MgCl2, 0.3 units of glucose-6-
phosphate dehydrogenase, 37 mM glucose [28]. Increase in
absorbance  was  measured for 3 min  at intervals of 30 s at
340  nm.  Glucokinase activity is expressed as M NADPH
(Nicotinamide adenine dinucleotide phosphate reduced),
decomposed/min/mg protein.
2.6.2. Glucose-6-phosphate dehydrogenase
The liver glucose-6-phosphate dehydrogenase (EC:
1.1.1.49) activity was  measured at 340 nm in a reac-
tion mixture containing 0.2 M Tris–HCl buffer (pH = 7.5),
0.5  × 10−2 M glucose-6-phosphate, 2 × 10−4 M NADP and
0.04 M MgCl2 [17]. Increase in absorbance was  mea-
sured for 3 min at 30 s intervals. Glucose-6-phosphate
dehydrogenase activity is expressed as M NADPH decom-
posed/min/mg protein.
2.7.  Assessment of oxidative stress
2.7.1. Determination of thiobarbituric acid-reactive
substances
Level of lipid peroxidation was measured by the method
of  [40]. Malondialdehyde (MDA) reacts with thiobarbi-
turic acid (TBA) to yield a colored compound. Brieﬂy, 10 l
homogenate was added to 70 l of double distilled water,
50  l of 50 mM  phosphate buffer, 10 l of 1 mM buty-
lated hydroxyl toluene, 75 l of 1.3% TBA. 50 l of 50%
icology R572 R. Kapoor, P. Kakkar / Tox
trichloroacetic acid was added to the reaction. The mix-
ture  was then incubated at 60 ◦C for 40 min  and kept on
ice  for 15 min. The reaction was stopped by the addition
10  l of 20% SDS (Sodium dodecyl sulfate). Absorbance was
measured at 530 nm and 600 nm and results expressed as
nM  MDA  formed/g protein using freshly diluted 1,1,3,3-
tetraethoxypropane to draw a standard curve.
2.7.2. Superoxide dismutase (SOD) activity
SOD activity in tissues of all the rats was estimated by
using  the method of [11]. Brieﬂy, 10 l of homogenate,
90 l of 30 mM  sodium tetra pyrophosphate buffer (pH
8.3),  30 l of 0.3 mM Nitro blue tetrazolium (NBT), 10 l
of  0.96 mM phenyl methyl sulphonate (PMS) and 40 l of
DDW  was added. The reaction was initiated by the addi-
tion  of 20 l 0.72 mM NADH. The reaction was stopped by
adding  50 l of glacial acetic acid. Absorbance was mea-
sured at 560 nm.  A single unit of enzyme is expressed
as 50% inhibition of NBT (Nitro Blue Tetrazolium) reduc-
tion/min/mg protein. Results were expressed as a unit of
SOD/min/mg protein.
2.7.3.  Catalase activity
Catalase  activity was assayed spectrophotometrically
using the method of [2]. Brieﬂy, the assay mixture of 1.5 ml
contained  980 l of 50 mM sodium phosphate buffer pH 7.0
and  20 l of homogenate (10–15 g protein). The reaction
was started by addition of 500 l of 30 mM hydrogen per-
oxide.  The decrease in absorbance was observed for 1 min
at  every 15 s at 240 nm.  Catalase activity is expressed as
mole  H2O2 decomposed/min/mg protein.
2.7.4. Glutathione peroxidase
Glutathione  peroxidase (GPx) activity was measured by
using  the method of [24]. The activity was expressed as
nmol  NADPH oxidized/min/mg protein.
2.7.5. Reduced glutathione and glutathione disulﬁde
(GSH & GSSG)
GSH  and GSSG were measured using the method
described by [7] with modiﬁcations. 50 l of tissue
homogenate was diluted with 50 l of 100 mM phosphate
buffer containing 1 mM EDTA (Ethylenediaminetetraacetic
acid). To this mixture 100 l of reaction buffer (295 M
5,  5′-dithio-bis (2-nitrobenzoic acid) (DTNB) was added
and  estimated at 412 nm immediately. The reduced GSH
standard was employed to obtain a standard curve.
Reduced GSH is expressed as M GSH/mg tissue. For esti-
mation of GSSG, 5 M NADPH was added to the reaction
mixture. GSSG was expressed as M GSSG/mg tissue.
2.8. Protein carbonyl content
Reactive  free radical oxidizes proteins and leads to
structural and functional changes. Protein carbonyl con-
tent  was estimated by the method of [19]. The homogenate
was diluted in a ratio 1:40 with phosphate-buffered saline
(PBS)  and centrifuged twice for 5–10 min  at 14,000 × g.
20%  TCA chilled was used to precipitate the diluted pro-
teins  followed by centrifugation for 3–5 min. A solutioneports 1 (2014) 569–581
of  10 mM DNPH in 2 N HCl was  added to the protein pel-
let  of each sample. Samples were allowed to stand in the
dark  at room temperature for 1 h with vortexing every 10
mins;  and further precipitated with 10–20% TCA (ﬁnal con-
centration) and centrifuged for 5 min. The supernatants
were discarded; the protein pellets were washed once
more  with 10–20% TCA, and then washed three times
with 1 ml  of ethanol/ethyl acetate (1:1, v/v) to remove
any free DNPH. Samples were then resuspended in 6 M
guanidine hydrochloride (GdmCl, dissolved in 2 N HCl) at
37 ◦C for 15 min  with vortex mixing. Carbonyl content was
determined from the absorbance at 366 nm using a molar
absorption coefﬁcient of 22,000 M−1 cm−1and expressed as
nanomoles per milligram of protein.
2.9. Measurement of ROS production in treated rats
ROS generation in rats of all groups was  measured by
the  method of [4] using Varioskan ﬂuorescent microplate
reader. The method employs the measurement of ROS gen-
eration  using the cell permeable ﬂuorescent dye DCFH-DA
(2′, 7-dichloroﬂuoresceindiacetate). Upon entering the cell,
DCFH-DA  is cleaved by the intracellular esterases leaving
DCFH (dichloroﬂuorescein) which is oxidized to DCF by the
oxidants  and its ﬂuorescence is taken as an indicator of oxi-
dant  production in the cell. In brief, hepatocytes of different
treatment groups were isolated and incubated for 30 min
with  DCFH-DA (5 g/ml) at 37 ◦C in the dark.
2.10. Mitochondrial membrane potential in treated rats
The  effect of the test substance on mitochon-
drial membrane potential was  assessed using JC-1
(5,5′,6,6′-tetrachloro-1,1′, 3,3′-tetraethylbenzimidazol-
carbocyanine iodide) ﬂouroprobe. Hepatocytes isolated
from  rats of different groups were incubated with
2.5 g/ml of JC-1 ﬂouroprobe at 37 ◦C in the dark for
30 min. m was  assessed by comparing the ﬂuorescence
(red) (Ex/Em-580/590 nm)/green (Ex/Em-510/527 nm)
using  Varioskan ﬂuorescent microplate reader [14].
2.11.  Expression of apoptotic and antiapoptotic genes
Liver tissue samples were collected on ice after sacri-
ﬁce and processed immediately for RNA isolation. Total
RNA  was  isolated from rats of treated and control groups
by  using the Trizol reagent (Invitrogen, Carlsbad, CA, USA)
according to manufacturer’s instructions. 3 g of total
RNA was  reverse transcribed (RT) into cDNA using Revert
Aid  H minus First Strand cDNA Synthesis Kit (Fermentas,
EU) as per manufacturer’s instructions. Complementary
DNA was used for semi-quantitative PCR (polymerase
chain reaction) using sets of speciﬁc primers as shown
in  Table 1. cDNA ampliﬁcation was carried out accord-
ing to the respective temperature proﬁle and the number
of  cycles for Bax, Bcl-2, Caspase3 and Caspase 9. GAPDH
(Glyceraldehyde 3-phosphate dehydrogenase) was  used as
internal  control. The product was  run on a 1.5% agarose gel
and  photographed on Ultraviolet transilluminator. Image J
software  1.44 (USA) was used to analyze PCR products. The
result  obtained was  normalized to GAPDH.
R. Kapoor, P. Kakkar / Toxicology R
Table 1
Primers used for expression of apoptotic and anti-apoptotic genes.
Genes Primers
Bcl-2 F 5′-ACTTTGCAGAGATGTCCAGTCAG-3′
R 5′-GTTCAGGTACTCAGTCATCCACAG-3′
Bax F 5′-GGAGGAAGTCCAGTGTCCAG-3′
R 5′-TGCAGAGGATGATTGCTGAC-3′
Caspase-3 F 5′-GAACGAACGGACCTGTGGACCT-3′
R 5′-GCCTCCACTGGTATCTTCTGGCAT-3′
Caspase-9 F 5′-TGAGCCAGATGCTGTCCCATACCAG-3′
R 5′-CCTGGGAAGGTGGAGTAGGACAC-3′
2
[
a
7
d
f
4
3
5
l
b
s
i
w
T
M
5
n
a
p
s
p
1
f
M
G
t
i
(
b
h
4
2
w
i
d
f
1
t
(GAPDH F 5′-GGCCAAGATCATCCATGACAACT-3
R 5′-ACCAGGACATGAGCTTGACAAAGT-3′
.12. Sub-cellular fractionation
Liver  nuclear extracts were obtained as described by
18].  Brieﬂy, tissue was washed with PBS, homogenized
nd suspended in lysis buffer containing 10 mM HEPES, pH
.9,  10 mM KCl, 0.1 mM EDTA, supplemented with 1 mM
ithiothreitol (DTT), protease inhibitor cocktail procured
rom Sigma Chemicals Co. (St. Louis, MO,  USA) and 0.4% NP-
0.  After 30 min  on ice, the lysate wase centrifuged (Sigma
K18,  Germany) at 16,000 × g in a micro centrifuge for
 min  at 4 ◦C. The supernatant was discarded, and the pel-
et  (nuclear fraction) was re-suspended in nuclear extract
uffer  (20 mM HEPES, pH 7.9, 0.4 mM NaCl, 1 mM EDTA,
upplemented with 1 mM DTT, a complete mini protease
nhibitor cocktail tablet and 10% glycerol). Pellet samples
ith  extraction buffer were incubated at 4 ◦C for an hour.
he  nuclear fraction was sonicated (Sartorius, Lab sonic
TM)  for 10 s, and centrifuged at 16,000 × g at 4 ◦C for
 min. The supernatant was then collected and used as a
uclear  extract.
Cytosolic and mitochondrial fractions were prepared
s described by [36]. Brieﬂy, tissue homogenates were
repared in ice-cold RIPA buffer. The homogenate was
uspended in ice-cold RIPA buffer (20 mM HEPES-KOH,
H- 7.5, 10 mM KCl, 1.5 mM MgCl2, 1.0 mM dithiothreitol,
.0 mM EDTA, 1.0 mM EGTA, 1.0 mM phenylmethylsul-
onyl ﬂuoride) and sonicated for 10 s (Sartorius, Lab sonic
TM).  The homogenate was centrifuged (Sigma 3K18,
ermany) at 800 × g for 4 min  at 4 ◦C. Supernatant was
hen centrifuged at 22,000 × g for 15 min  at 4 ◦C. Result-
ng supernatant was used as cytosolic fraction and pellet
mitochondria) was re-suspended in cold RIPA buffer, incu-
ated  on ice for 30 min  followed by sonication for 10 s. The
omogenate was centrifuged at 15,000 × g for 15 min  at
◦C. The resulting supernatant was mitochondrial fraction.
.13.  Immunoblot analysis
The  protein content corresponding to each treatment
as quantiﬁed using the method of [21]). Samples were
ncubated with loading dye for 5 min  at 96 ◦C and imme-
iately kept on ice. Sixty microgram of protein sample
rom cytosolic or mitochondrial fraction was separated on
2%  SDS – polyacrylamide gel electrophoresis and elec-
ro  blotted on polyvinylidene diﬂuoride (PVDF) membrane
HybondTM P Amersham biosciences, UK limited, NA). Theeports 1 (2014) 569–581 573
membrane was blocked for non-speciﬁc sites with 1X
blocking buffer and washed using Tris buffered saline (TBS)
containing 0.1% Tween-20. The membrane was  then incu-
bated  for 1 h with speciﬁc polyclonal IgG antibodies of
AIF,  Endo-G, Cox IV, Lamin-B and -Actin (Santa Cruz
Biotechnology, Inc.) at 1:500 dilutions. This was followed
by  washing with PBS and incubated with respective sec-
ondary  antibody in 1:1000 dilutions. The membrane was
processed and developed using ImmobilonTM Western
Chemiluminescent Horse Raddish peroxidase substrate kit.
(Millipore,  Corporation, MA,  USA). -actin was used as
internal standard. PageRulerTM Prestained Protein Ladder
(SM-0671 from Fermentas, EU) was  used to determine the
molecular  weight of the protein bands. Densitometry of the
bands  obtained was  done using NIH software Image J ver-
sion  1.41 (USA). The result is expressed as arbitrary units
for  each experimental band.
2.14. Asp-Glu-Val-Asp-Speciﬁc caspase activity
Caspase activity was  assayed by reaction in the iso-
lation buffer containing 10 mM Tris–HCl buffer, pH 7.6,
5  mM MgCl2, 1.5 mM potassium acetate, 2 mM DTT (Dithio-
threitol) and protease inhibitor cocktail. To the reaction
mixture was added 50 g of cytosolic protein and 50 M
Asp-Glu-Val-Asp-pNA in the isolation buffer. General cas-
pase  activity was evaluated by enzymatic cleavage of
chromophore p-nitroanilide (PNA) from the substrate
N-acetyl-Asp-Glu-Val-Asp-pNA (Sigma). The reaction mix-
tures  were incubated at 37 ◦C for 1 h, and the formation
of pNA was measured at 405 nm using Spectramax PLUS
384  microplate reader (Soft max  pro version 5.1; Molecular
Devices, USA) [31].
2.15.  Statistical analysis
Data  are expressed as mean ± SE. Data was analyzed
on SPSS software version 14.0 using student’s t-test and
one-way ANOVA (Analysis of variance). *P < 0.05, **P < 0.01,
***P  < 0.001 were used as the criterion for signiﬁcance.
3. Results
3.1. Oral glucose tolerance test, fasting blood glucose and
body  weight
After the induction and conﬁrmation of the diabetic con-
dition,  the animals were subjected to oral glucose tolerance
test  (OGTT). Fig. 1 shows the glycemic proﬁle assessed in
rats  30, 60, 90 and 120 min  after the administration of glu-
cose.  A constant increase in blood glucose was observed in
the  diabetic group until 90 min  after administration of glu-
cose,  which subsequently declined at 120 min. However,
the  pattern was  not observed in the untreated diabetic
group, which continued to have elevated blood glucose
at  the culmination of the test. Blood glucose reached its
peak  around 30 min after glucose administration and max-
imum  reduction in blood glucose was observed at 90 min
in  glybenclamide as well as naringenin treated rats. A
dose  of 50 mg/kg bwt  and 100 mg/kg bwt of naringenin
reduced blood glucose by 63% and 68% respectively, in
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Fig. 1. Dose optimization of naringenin and the effect of naringenin on fasting blood glucose. (a) Effect of three doses of Naringenin, i.e., 25 mg/kg bwt,
50  mg/kg bwt and 100 mg/kg bwt on blood glucose during oral glucose tolerance test. (b) Fasting blood glucose in control, diabetic and treated diabetic rats.
ferenceEach  value represents the mean ± SE of six rats. # Denotes signiﬁcant dif
signiﬁcant  difference compared with diabetic control.
120 min  and the response was comparable to standard
drug glybenclamide. Since 50 mg/kg bwt  and 100 mg/kg
bwt  naringenin showed an almost similar response, a lower
dose  of naringenin was taken up for further experiments
(Fig. 1).
Though the initial weight of all groups was almost sim-
ilar,  induction of diabetes caused a signiﬁcant reduction
(P  < 0.001) in body weight. Naringenin, during its co-
treatment, prevented the decrease in body weight caused
due  to diabetes. A signiﬁcant increase of 2.08-fold in body
weight  of diabetic rats was observed when co-treated with
naringenin as compared to untreated diabetic rats. How-
ever,  with respect to control, no signiﬁcant change was
observed in weight of control rats treated with naringenin
alone (supplementary data Fig. S1).
A signiﬁcant (P < 0.001) increase of 3.48-fold in fasting
blood glucose of diabetic rats was observed when com-
pared  to control rats and the increase was up to 4.12-fold
at  the end of four weeks. It was observed, when naringenin
(50 mg/kg bwt) was given prior to the injection of strep-
tozotocin (co-treatment of naringenin), it prevented the
increase  of blood glucose in diabetic range of 250 mg/dl.
However, non-signiﬁcant increase in blood glucose due
to  streptozotocin was observed, which was restored to
normal  levels by further three-week exposure of narin-
genin. Diabetic rats treated with naringenin (50 mg/kg
bwt) showed signiﬁcant decline of 70.01% (P < 0.001)
in  fasting blood glucose level. However, standard drug
Table 2
Naringenin modulated the serum biochemical parameters in rats altered due to i
SGOT (U/L) SGPT (U/L) ALP (U/L) Crea
Ctrl 85.9 ± 5.8 234.7 ± 9.4 66.5 ± 7.9 0.5 
Diab  269.3 ± 7.3# 599.4 ± 15.6# 381.3 ± 11.0# 1.2 
CoN 114.8 ± 8.5*** 245.8 ± 11.1*** 64.5 ± 3.9*** 0.5 
PoN 127.9 ± 5.8*** 270.9 ± 12.8*** 74.32 ± 5.4*** 0.5 
Glib 150.3 ± 8.4** 289.5 ± 14.6*** 130.9 ± 8.6** 0.6 
Sil 132.4 ± 10.7** 254.8 ± 11.1** 102.5 ± 4.4*** 0.4 
CtN 75.6 ± 5.9 241.9 ± 19.6 61.7 ± 8.3 0.4 
Each value represents the mean ± SE of six rats. Ctrl: Control rats; Diab: Diabetic r
induction;  PoN: Diabetic rats treated with naringenin after diabetes induction; G
rats  treated with Silymarin; CtN: Control rats treated with naringenin. # Denote
*** P < 0.001 denotes signiﬁcant difference compared with diabetic control. compared with control rats. *P < 0.05, **P < 0.01 and ***P < 0.001 denotes
glybenclamide, decreased the fasting blood glucuose level
by  53.10% as compared to untreated diabetic rats. Control
rats  treated with naringenin did not show any signiﬁcant
change in fasting blood glucose level (Fig. 1).
3.2. Biochemical parameters
A  signiﬁcant (P < 0.001) elevation in the activity of
marker hepatocyte enzymes, GOT (3.16-fold) and GPT
(2.22-fold); renal marker creatinine (2.85-fold), ALP (5.73-
fold)  and total cholesterol (2.02-fold) (Table 2) in serum
of  diabetic animals was  observed. Naringenin signiﬁ-
cantly (P < 0.001) modulated the levels of liver and kidney
marker enzymes, cholesterol and glucose levels. Narin-
genin (50 mg/kg bwt) was  found effective during both the
treatment schedules (co and post) which were comparable
to  standard drugs, glybenclamide and known antioxidant
silymarin. However, no change was  observed in control rats
treated  with naringenin alone.
3.3. Antioxidant status of diabetic rats
3.3.1. Catalase activity
Catalase  activity was  signiﬁcantly (P < 0.001) reducedby 69.07% in the liver of diabetic rats as compared to
non-diabetic rats. Diabetic rats co- and post- treated
with naringenin exhibited signiﬁcantly higher catalase
activity compared to untreated diabetic rats. Signiﬁcant
nduced diabetes.
tinine (mg/dl) Total glucose (mg/dl) Cholesterol (mg/d l)
± 0.01 76.7 ± 4.9 122.4 ± 11.2
± 0.05# 494.8 ± 7.5# 255.9 ± 13.4#
± 0.02*** 94.8 ± 5.2*** 119.7 ± 8.8***
± 0.03*** 128.8 ± 6.4*** 118.9 ± 0.7***
± 0.05** 203.8 ± 16.5* 122.2 ± 1.2**
± 0.01** 144.5 ± 10.3** 132.6 ± 8.6**
± 0.02 77.2 ± 8.1 91.2 ± 2.8
ats; CoN: Diabetic rats co-treated with naringenin during streptozotocin
lib: Diabetic rats treated with standard drug glybenclamide; Sil: Diabetic
s signiﬁcant difference compared with control rats; * P < 0.05; ** P < 0.01;
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Table 3
Effect of naringenin on antioxidant status of diabetic rats.
Groups/activity SOD activity (SOD
units/min/mg protein)
Catalase activity (mole H2O2
decomposed/min/mg protein)
GPx activity (nmol NADPH
oxidized/min/mg  protein)
Redox ratio
(GSH/GSSG)
Ctrl 55.4 ± 1.5 12.2 ± 0.4 102.1 ± 3.3 4.8 ± 0.2
Diab  23.6 ± 1.8# 3.7 ± 0.6# 48.2 ± 2.8# 0.9 ± 0.1#
Con 45.5 ± 1.7*** 8.3 ± 0.9** 75.4 ± 2.4** 3.4 ± 0.6**
PoN 47.5 ± 1.5** 9.9 ± 0.8** 85.7 ± 2.2** 3.4 ± 0.5***
Glib 40.0 ± 1.4** 7.0 ± 0.3* 74.3 ± 2.2** 2.5 ± 0.2*
Sil 38.8 ± 0.8* 7. 9 ± 0.5* 70.5 ± 3.2** 3.6 ± 0.3***
CtN 63.4 ± 1.4 13.5 ± 0.5 115.1 ± 4.5 4.9 ± 0.3
Each value represents the mean ± SE of six rats. Ctrl: Control rats; Diab: Diabetic rats; CoN: Diabetic rats co-treated with naringenin during streptozotocin
induction; PoN: Diabetic rats treated with naringenin after diabetes induction; Glib: Diabetic rats treated with standard drug glybenclamide; Sil: Diabetic
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** P < 0.001 denotes signiﬁcant difference compared with diabetic contro
nhancement of 2.24-fold (P < 0.001; co-treatment) and
.67-fold (P < 0.001; post-treatment) in catalase activity
as  observed in naringenin (50 mg/kg bwt) treated animals
Table  3). No signiﬁcant change in the activity of catalase
as  observed in control rats treated with naringenin.
.3.2. GPx Activity
The  activity of Glutathione peroxidase (GPx), a key
edox regulator, was found to decrease signiﬁcantly by
2.75%  (P < 0.001) in diabetic rats as compared to non-
iabetic rats. Signiﬁcant enhancement of 56.43% (P < 0.01)
nd  77.80% (P < 0.01) in GPx activity was found in diabetic
ats  co and post treated with naringenin. The response to
aringenin treatment was comparable to standard drug,
lybenclamide and known free radical quencher silymarin
Table 3).
.3.3.  SOD Activity
Free  radicals generated due to diabetes induction
aused alterations in SOD activity, the ﬁrst line of antiox-
dant  defense. As summarized in Table 3, signiﬁcant
P < 0.001) decrease of 57.35% in SOD activity was observed
n  the liver of diabetic rats as compared to non-diabetic
ats. Co-treatment of naringenin signiﬁcantly (P < 0.001)
nhanced SOD activity by 84.6%, as compared to diabetic
ats.  Standard drug glybenclamide was able to signiﬁcantly
estore the activity by 69.4%.
.3.4.  Glutathione redox ratio
A decrease in the redox ratio (GSH/GSSG) indicates an
ncrease in the reductive stress and marks the onset of
arious vascular diseases and complications. The diabetic
roup  showed signiﬁcant (P < 0.001) decrease in the redox
atio  indicating the generation of oxidative stress. Co-
reatment of naringenin increased the redox ratio by 3.77-
old  (P < 0.001), while in its post exposure, it increased to
.72-fold  (P < 0.001) which was comparable to the increase
bserved due to glybenclamide administration (Table 3).
.3.5.  Lipid peroxidation in diabetic rats
Free radicals generated due to hyperglycemia caused
eroxidative damage to the tissues, leading to increase
n  levels of MDA  (malondialdehyde) formation. The con-
entration of malondialdehyde, a terminal compound of signiﬁcant difference compared with control rats; * P < 0.05; ** P < 0.01;
lipid  peroxidation, is commonly used as an index of oxida-
tive  injury due to free radicals In the liver of diabetic rats,
signiﬁcant (P < 0.001) increase of 2.74-fold in lipid perox-
idation was  found. A decrease of 2.21-fold (P < 0.001) in
MDA  formation was  observed in diabetic rats co-treated
with 50 mg/kg bwt  naringenin. The decrease in MDA  for-
mation  by naringenin during co- and post-treatment was
similar  to standard drug, glybenclamide (Fig. 2a).
3.3.6. Protein carbonyl content
In  the liver of diabetic rats, a signiﬁcant increase in
protein oxidation (2.71-fold) was seen as compared to
the  vehicle control group (Fig. 2b). However, Naringenin
signiﬁcantly decreased the protein oxidation level by 2.08-
fold  and 2.11-fold in co- and post-treatment, respectively
(P < 0.001) compared with the non-treated diabetic rats.
The  response of naringenin was  better as compared to
standard drug glybenclamide. No signiﬁcant damage was
observed  in control rats treated with naringenin.
3.4. Carbohydrate metabolizing enzymes
3.4.1. Glucokinase
Glucokinase (EC 2.7.1.2), is an important glucose metab-
olizing enzyme, which facilitates glucose phosphorylation
to glucose-6-phosphate. Glucokinase plays an important
role in the regulation of carbohydrate metabolism by
acting  as a glucose sensor, and manages the glucose
metabolism during its depletion or excess in blood. Signiﬁ-
cant  (P < 0.001) decrease of 2.32-fold in hepatic glucokinase
activity was  seen in diabetic rats. Maximum enhancement
of 1.88-fold in the activity of glucokinase was seen during
co-treatment of naringenin (Fig. 2c).
3.4.2. Glucose-6-phosphate dehydrogenase
During diabetes, change in glycolytic, NADPH gener-
ating and gluconeogenic enzymes is observed in liver. In
the  liver of diabetic rats, the level of glucose-6-phosphate
dehydrogenase was signiﬁcantly (P < 0.01) reduced by
2.31-fold, which was found to increase during differ-
ent treatment schedules of naringenin. A maximum
enhancement in the activity of glucose-6-phosphate dehy-
drogenase observed was  1.97-fold in co-treatment of
naringenin (Fig. 2d) and the response due to phytochemical
was comparable to glybenclamide.
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Fig. 2. Effect of naringenin on oxidative damage and glucose metabolizing enzymes. (a) MDA levels in liver of control, diabetic and diabetic treated rats.
(b)  Protein carbonyl content in control, diabetic and diabetic treated rats. (c) Glucose-6 phosphate dehydrogenase activity in control, diabetic and treated
rats.  (d) Glucokinase activity in control, diabetic and treated diabetic rats. Each value represents the mean ± SE of six rats. # Denotes signiﬁcant difference
igniﬁcacompared  with control rats. *P < 0.05, **P < 0.01 and ***P < 0.001 denotes s
3.5. ROS generation
Various  metabolic pathways are considered to cause
an  increase in ROS generation, during diabetes. Intracel-
lular ROS generation in different treatment groups was
estimated using DCFH-DA ﬂouro-probe. Hepatocytes iso-
lated  from diabetic rats exhibited signiﬁcantly enhanced
ROS generation which was 4.33-fold (P < 0.001) as com-
pared  to control. Hepatocytes isolated from diabetic rats
co-  and post-treated with naringenin showed a signiﬁcant
(P  < 0.001) decline in the ROS generation as assessed by
DCFH  ﬂourescence, which was 2.57 and 2.34-fold decrease
respectively in comparison to hepatocytes isolated from
diabetic  rats. Whereas, 1.60-fold decrease in ROS gener-
ation  was observed in the glybenclamide treated group
(Fig.  3a).
3.6.  Mitochondrial membrane potential
Activation of a cell death program or apoptosis is
triggered by initiation of certain cascadic events, which
include mitochondrial depolarization and the subsequent
release of pro-apoptotic factors. Alteration in mitochon-
drial trans-membrane electrical potential was investigated
in  primary hepatocytes isolated from rats of differentnt difference compared with diabetic control.
treatment groups. As mitochondria get depolarized, ﬂu-
orescence of the JC-1 dye changes from red to green.
An increase of monomeric JC-1 molecules (green ﬂuo-
rescence) due to a decrease of mitochondrial membrane
potential occurred in hepatocytes isolated from diabetic
rats. A 3.53-fold (P < 0.001) decrease in the ratio of red to
green  ﬂuorescence was seen in hepatocytes of diabetic rats
indicating  depolarization. Hepatocytes isolated from dia-
betic  rats co-treated with naringenin exhibited a signiﬁcant
enhancement in red/green ﬂuorescence with a maximum
increase of 2.75-fold (P < 0.001) observed in hepatocytes
isolated from naringenin co-treated rats (Fig. 3b) indicating
prevention of depolarization of mitochondria.
3.7. Expression of Bax and Bcl-2
Depolarized mitochondria mark the release of various
apoptotic and anti-apoptotic factors, which trigger the
downstream cascade of cell death. We  further investi-
gated the scheme of events involved in diabetes-induced
stress, which included changes in apoptotic genes like
Bax,  and antiapoptotic gene Bcl-2. Levels of apoptotic
and anti-apoptotic genes and proteins were assessed. At
the  transcriptional level, the amount of Bax, which was
increased by 2.33-fold (P < 0.001) in diabetic rats, showed
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Fig. 3. Protection accorded by naringenin in ROS generation and MMP  of diabetic rats. (a) ROS generation assessed by spectroﬂuorometry using ﬂuoroprobe
DCFH-DA.  Results are represented as fold of DCF ﬂuorescence as compared to control. (b) Induction of mitochondrial membrane collapse in hepatocytes
isolated  from control, diabetic and diabetic treated rats. Mitochondrial membrane potential of treated and control cells was assessed by ﬂuorescent
spectrophotometer using JC-1. Decrease in the red (polarized)/green (depolarized) ﬂuorescence ratio reﬂects increased number of depolarized mitochondria.
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 decline of 2.08-fold (P < 0.01) on treatment with narin-
enin. A signiﬁcant increase of 2.70-fold (P < 0.001) in
ax  protein level was detected in diabetic rats. Narin-
enin treated diabetic rats showed a corresponding decline
2.52-fold) in Bax protein level. Diabetes caused signiﬁcant
eduction in the level of Bcl-2, which was again restored by
aringenin  (3.62-fold). The effect of naringenin was  much
ronounced than that of standard drug glybenclamide and
nown  antioxidant silymarin (Fig. 4).
.8. Translocation of mitochondrial AIF and Endo-GDuring apoptosis, release of apoptotic proteins like AIF
nd  Endo-G from mitochondria and then its translocation
o the nucleus are considered important events. Release
ig. 4. Effect of naringenin on transcriptional and translational level of Bax and B
sing  GAPDH as internal control. (b) Shows protein level of Bax and Bcl-2 as estima
hows  relative intensity normalized to internal control. Results are shown as me
nd  *P < 0.05, **P < 0.01 and ***P < 0.001 denotes signiﬁcant difference compared w
alues.compared with control rats. *P < 0.05, **P < 0.01 and ***P < 0.001 denotes
eferences to color in this ﬁgure legend, the reader is referred to the web
and  translocation of these two important proteins under
high  glucose stress has been established in our earlier
in  vitro studies [14,15]. During apoptosis, Endo-G which
resides within the mitochondria translocates to the nucleus
and  causes large scale DNA fragmentation. To analyze the
potential  involvement of AIF and Endo-G during progres-
sion  of diabetes and the onset of its complications, the
protein levels of AIF and Endo-G were quantiﬁed by west-
ern  blot in mitochondrial and nuclear fraction. In diabetic
rats,  a signiﬁcant decrease of 4.91-fold in the level of AIF in
mitochondria was  accompanied by a substantial increase
of  2.92-fold in the nuclear fraction. Treatment of dia-
betic rats with naringenin exhibited signiﬁcant (P < 0.001)
reduction of AIF in mitochondria. Similar to the pattern
observed for AIF, diabetic rats showed a marked increase of
cl-2 of control and diabetic rats. (a) Shows m-RNA level of Bcl-2 and Bax,
ted through western blot, -actin served as loading control. Densitometry
an ± S.E. # Denotes signiﬁcant difference compared with control values
ith diabetic rats. # Denotes signiﬁcant difference compared with control
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Fig. 5. Translocation of AIF and Endo G from mitochondria to nucleus. Diabetes induced cell death involves AIF and Endo-G release from mitochondria.
(a)  Shows the changes in immunoreactivity for AIF in the mitochondrial and nuclear fractions. Mitochondrial AIF was depleted signiﬁcantly after diabetes
induction  with Cox (IV) serving as internal control. (b) Shows Endo-G release from mitochondria due to permeability changes and its translocation to
nucleus.  Changes in the immuno-reactivity for Endo-G in the mitochondrial and nuclear fractions were assessed. Mitochondrial Endo-G was depleted
l for mi
sults ar
ifferencsigniﬁcantly  after diabetes induction. Cox (IV) served as internal contro
Densitometry  shows relative intensity normalized to internal control. Re
control  values and *P < 0.05, **P < 0.01 and ***P < 0.001 denotes signiﬁcant d
with  control values.
2.84-fold (P < 0.001) in the level of Endo-G in nuclear frac-
tion  and decrease in the mitochondrial fraction by 2.75-fold
(P  < 0.001). Level of translocated Endo-G was signiﬁcantly
modulated by naringenin. The protection accorded by
naringenin was  observed to be more pronounced than that
of  glybenclamide and silymarin (Fig. 5).
3.9. Study of caspase9/3 genes, proteins and caspase 3
enzymatic activity
Release  of various apoptotic factors like Bax, AIF and
Endo-G result in increased expression level of effector and
executor  caspases. With this view, the expression levels
of  caspase-9 and caspase-3 were determined along with
caspase-3 activity. Diabetic rats exhibited an increased
gene expression of caspase-3 (P < 0.001) by 2.17-fold.
Expression of caspase-3 was decreased in naringenin co-
treated  rats by 1.48-fold (Fig. 6). The result obtained from
the  gene expression study was consistent with results
obtained in protein expression. Enzymatic activity of
caspase-3 was signiﬁcantly (P < 0.01) increased by 3.47-fold
in  diabetic rats. Naringenin modulated the activity and a
signiﬁcant  reduction of 2.35-fold (P < 0.001) was observed
with  co-treatment of naringenin. A similar response was
observed  during post-treatment with naringenin and sily-
marin,  which was more efﬁcient than that of standard
drug glybenclamide. The expression level of caspase-9
was reduced (P < 0.001) by 1.89-fold and was signiﬁcantly
ameliorated by naringenin at both transcriptional and
translational level.tochondria and Lamin-B served as internal control for nuclear fraction.
e shown as mean ± S.E. # Denotes signiﬁcant difference compared with
e compared with diabetic rats. # Denotes signiﬁcant difference compared
3.10.  DNA fragmentation
Certain  morphological and biochemical characteristics
are related to apoptotic cell death. One such qualitative
feature of apoptosis is DNA fragmentation. In cells under-
going  apoptosis, DNA is fragmented into smaller fragments
of  about 180-bp oligomers and multiple thereof (360, 540,
etc.),  which appears as a DNA ladder when run on an
agarose gel. DNA samples from the control rats and rats
post-  and co- treated with naringenin showed no distinct
bands, but high molecular weight was  retained on the top
portion  of the gel (Fig. 7). In contrast, a number of low
molecular weight bands showing speciﬁc laddering pattern
were  observed in the DNA samples obtained from diabetic
rats.  Control rats treated with naringenin did not show DNA
fragmentation.
4.  Discussion
Diabetes is a complex metabolic disorder with char-
acteristic modulation of glucose metabolism leading to
excessive ROS production and generation of various
diabetic complications like nephropathy, neuropathy, car-
diopathy  and even hepatopathy. Various glucose metabolic
pathways are mainly responsible for the generation of ROS
and  are involved in many of the micro- and macrovascu-
lar complications that are associated with diabetes. Under
normal  conditions, ROS at its low level functions as “redox
messenger” in intracellular signaling and regulation. On
the  contrary, when major glucose metabolizing pathways
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Fig. 6. Effect of naringenin on transcript and protein levels of caspase-3/9 and enzymatic activity of caspase-3. (a) Shows activation of caspase-3 and
caspase-9  as evident from the appearance of its cleaved product. (b) Shows m-RNA level of apoptotic genes-caspase-3 and caspase-9 using GAPDH as
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igniﬁcant  difference compared with treated rats.
ome into action, ROS is generated leading to oxidative
odiﬁcation of cellular macromolecules, disturbed pro-
ein  function and activated cell death signaling. High blood
lucose,  in addition to the generation of free radicals,
epresses the level of natural antioxidant defense com-
ounds such as ascorbic acid and GSH present in the body
30],  thereby causing major antioxidant imbalance. Hence,
anagement and sustenance of antioxidant status can be
n  effective panacea for diabetes. In our earlier studies, we
ave  reported the relation of high glucose to the gener-
tion of ROS and onset of apoptosis in cultured primary
ig. 7. Modulation of diabetes induced DNA fragmentation. Intra-
ucleosomal DNA fragmentation in control, diabetes, diabetes treated rats
a).  Lane 1: DNA Marker 100 bp: Lane 2: DNA isolated from Control rats,
ane 3: DNA from diabetic rats Lane 4: Naringenin co-treated diabetic rats.
ane  5: Naringenin post-treated diabetic rats, Lane 6: Diabetic rats treated
ith Glybenclamide. Lane 7: Diabetic rats treated with Silymarin, Lane 8:
ontrol  rats treated with naringenin.al control, (c) shows caspase-3 enzymatic activity of control and treated
ed with control values and *P < 0.05, **P < 0.01 and ***P < 0.001 denotes
hepatocytes. Based on our previous ﬁndings [14,15], the
present  in vivo study was taken up to further investigate
the molecular mechanisms underlying diabetes-induced
apoptosis in liver of rats and its amelioration by natural
phyto-constituent naringenin.
In  the present investigation, we observed the anti-
hyperglycaemic effect of naringenin through the oral
glucose tolerance test in which even 50 mg/kg bwt  dose
signiﬁcantly improve glucose tolerance. Induced diabetes
is  marked by severe diminution of body weight, which
may  be attributed to loss or degradation of structural
proteins [41]. In our present study, we  observed that
diabetes-induced decrease in body weight was  prevented
by  naringenin, which is in accordance with earlier studies
reporting, prevention of body weight loss in diabetic rats
by  the usage of phytochemicals or medicinal plant extracts
[30].
Glucokinase is one of the important enzymes in
the glucose catabolism which phosphorylates glucose to
glucose-6-phosphate [1]. In our study, we  report decreased
glucokinase activity in the liver of diabetic rats, as reported
earlier [22,25,26,30]. Diabetic rats treated with naringenin
(50  mg/kg bwt) showed an enhancement in glucokinase
activity to near control levels. We  also found a decrease
in the activity of glucose 6-phosphate dehydrogenase
in diabetic rats. The literature suggests the decrease in
this  enzyme activity can inhibit the pentose phosphate
pathway in diabetic conditions [1]. Diabetic rats treated
with naringenin and silymarin signiﬁcantly enhanced liver
glucose-6-phosphate dehydrogenase activity. This results
in  an increased production of the reducing agent, NADPH,
with  the collateral decrease in oxidative stress.Role of ROS in the generation and progression of dia-
betes is well postulated and has been reported by many
researchers. Our ﬁndings on the disturbed antioxidant sta-
tus  due to diabetes are in accordance with various earlier
icology R580 R. Kapoor, P. Kakkar / Tox
reports [13,16,43]. Diabetes-induced free radicals caused
peroxidative damage to the tissues, leading to increase in
the  levels of MDA  formation and protein carbonyl content.
Free  radicals generated due to different glucose metabo-
lizing pathways can be well abrogated by phytochemicals
having good antioxidant property. Naringenin, a ﬂavonoid,
was  able to restore the modulation seen in SOD, Catalase,
GPx  activity and redox ratio due to diabetes induction.
Moreover, naringenin showed signiﬁcant reduction of lipid
peroxidation and protein carbonyl content in diabetic rats.
These  results support the earlier ﬁndings reporting the use
of  phytochemicals in effective treatment of tissue damage
during  diabetes [22,43]. The in vivo hepatoprotection and
antioxidant effect of naringenin could be attributed to its
anti-hyperglycaemic effect. Authors hence presume that
by  preventing hyperglycaemia the diabetes-induced liver
damage  may  be prevented.
Mitochondrial  dysfunction has been proposed as a crit-
ical  modulator of ROS generation and onset of apoptosis
during diabetic complications. Loss of mitochondrial mem-
brane  potential is observed due to excess mitochondrial
ROS production. Depolarization of the mitochondrial inner
membrane potential (m) in streptozotocin-induced
diabetic rats suggests the loss of mitochondrial membrane
integrity and formation of mitochondrial pore. Several
studies using in vitro cell culture or in vivo animal models,
including our own, have suggested that high glucose cause
loss  of mitochondrial membrane potential [13–15,38,43].
Several apoptogenic proteins like Cyt-c, AIF, and Endo-G
are  said to be released through pores formed in mitochon-
drial membrane. Naringenin, by preventing excessive ROS
production, was effective in maintaining the mitochondrial
membrane potential and thereby preventing the release of
various  apoptogenic factors from mitochondria. As a conse-
quence,  the expression of caspase-3 and caspase-9 which
was  upregulated in diabetic rats due to release of apop-
togenic factors from mitochondrial pores was prevented
in  naringenin treated rats, thus checking the formation of
apoptosome with caspases.
An important ﬁnding in this study is that diabetes causes
the  release of certain factors like AIF and Endo-G that
play an important role in DNA damage. With the forma-
tion of pore in the mitochondrial membrane, factors like
AIF  and Endo-G leak out and cause integral damage to
DNA  and nuclear material. Streptozotocin induced dia-
betic  rats showed release of these proteins, suggesting
their translocation from mitochondria to the nucleus is an
important  step required for apoptosis to take place. Our
ﬁndings regarding the release of these apoptogenic fac-
tors  are in accordance with earlier studies reporting the
release  of AIF and Endo-G during diabetes [8,9]. We have
also  reported the involvement of these two proteins in
the  development of apoptosis under high glucose stress
[14,15]. With the translocation of AIF and Endo-G from
its  resident place, the enhanced DNA damage was  seen
in  diabetic rats. Naringenin, by restoring mitochondrial
membrane potential, restrained the translocation of AIF
and  Endo-G to the nucleus which precluded DNA dam-
age  and thereby prevented tissue damage associated with
diabetes.  Inhibition of apoptosis or redox imbalance was
more  pronounced in the case of naringenin as comparedeports 1 (2014) 569–581
to  standard drug glybenclamide or known plant-derived
antioxidant silymarin. This property of naringenin marks it
as  a potential candidate for management of diabetes under
the  experimental conditions.
5.  Conclusion
In the present study, various events related to gen-
eration and progression of diabetic complications during
streptozotocin induced diabetes was  investigated. The
current ﬁndings propose sequential events that lead to
diabetic  hepatopathy. Decreased body weight, altered
activity of liver and kidney marker enzymes, altered
carbohydrate metabolizing enzyme activities, analyses
of  the expression of Bcl-2 family genes and proteins,
antioxidant enzyme activities, tissue MDA  formation, gen-
eration  of ROS, translocation of AIF, Endo G and activation
of  caspase 9/3 suggest that apoptosis involve in dia-
betic hepatopathy is via activation of the AIF-caspase
independent/mitochondrial apoptotic pathway and DNA
damage.  Naringenin, an active constituent of traditionally
used antidiabetic plant Citrus paridisi, exerted the anti-
hyperglycemic effect by preventing oxidative stress and
resultant apoptotic events during diabetes-induced liver
damage.  Taken together, these ﬁndings suggest that narin-
genin  has potential as adjunct therapy for the management
of diabetic hepatopathy
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